135 related articles for article (PubMed ID: 21044639)
21. Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice.
Medhurst AD; Roberts JC; Lee J; Chen CP; Brown SH; Roman S; Lai MK
Br J Pharmacol; 2009 May; 157(1):130-8. PubMed ID: 19222483
[TBL] [Abstract][Full Text] [Related]
22. Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H
Riddy DM; Cook AE; Shackleford DM; Pierce TL; Mocaer E; Mannoury la Cour C; Sors A; Charman WN; Summers RJ; Sexton PM; Christopoulos A; Langmead CJ
Neuropharmacology; 2019 Jan; 144():244-255. PubMed ID: 30359639
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic potential of histamine H3 receptor antagonists in dementias.
Chazot PL
Drug News Perspect; 2010 Mar; 23(2):99-103. PubMed ID: 20369074
[TBL] [Abstract][Full Text] [Related]
24. Activation of the histaminergic H3 receptor induces phosphorylation of the Akt/GSK-3 beta pathway in cultured cortical neurons and protects against neurotoxic insults.
Mariottini C; Scartabelli T; Bongers G; Arrigucci S; Nosi D; Leurs R; Chiarugi A; Blandina P; Pellegrini-Giampietro DE; Passani MB
J Neurochem; 2009 Sep; 110(5):1469-78. PubMed ID: 19549072
[TBL] [Abstract][Full Text] [Related]
25. Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.
Wang L; Liu BJ; Cao Y; Xu WQ; Sun DS; Li MZ; Shi FX; Li M; Tian Q; Wang JZ; Zhou XW
Mol Neurobiol; 2018 Jun; 55(6):4731-4744. PubMed ID: 28717968
[TBL] [Abstract][Full Text] [Related]
26. alpha7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation.
Ren K; Thinschmidt J; Liu J; Ai L; Papke RL; King MA; Hughes JA; Meyer EM
Neuroscience; 2007 Mar; 145(1):314-22. PubMed ID: 17218065
[TBL] [Abstract][Full Text] [Related]
27. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
[TBL] [Abstract][Full Text] [Related]
28. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic characterization of S 38093, a novel inverse agonist at histamine H3 receptors.
Sors A; Panayi F; Bert L; Favale D; Nosjean O; Audinot V; Arrang JM; Buisson B; Steidl E; Delbos JM; Huhtala T; Kontkanen O; Chollet AM; Casara P; Lestage P
Eur J Pharmacol; 2017 May; 803():11-23. PubMed ID: 28336400
[TBL] [Abstract][Full Text] [Related]
30. A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands.
Miller TR; Baranowski JL; Estvander BR; Witte DG; Carr TL; Manelli AM; Krueger KM; Cowart MD; Brioni JD; Esbenshade TA
Assay Drug Dev Technol; 2008 Jun; 6(3):339-49. PubMed ID: 18593375
[TBL] [Abstract][Full Text] [Related]
31. Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease.
Patnaik R; Sharma A; Skaper SD; Muresanu DF; Lafuente JV; Castellani RJ; Nozari A; Sharma HS
Mol Neurobiol; 2018 Jan; 55(1):312-321. PubMed ID: 28861757
[TBL] [Abstract][Full Text] [Related]
32. A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia.
Haig GM; Pritchett Y; Meier A; Othman AA; Hall C; Gault LM; Lenz RA
J Alzheimers Dis; 2014; 42(3):959-71. PubMed ID: 25024314
[TBL] [Abstract][Full Text] [Related]
33. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
[TBL] [Abstract][Full Text] [Related]
34. Selective H3 receptor (H3R) blockade: broad efficacy in cognition and schizophrenia.
Fox GB; Esbenshade TA; Pan JB; Browman KE; Zhang M; Ballard ME; Radek RJ; Miner H; Bitner RS; Krueger KM; Yao BB; Faghih R; Rueter LE; Komater VA; Drescher KU; Buckley MJ; Sullivan JP; Cowart MD; Decker MW; Hancock AA
Inflamm Res; 2005 Apr; 54 Suppl 1():S23-4. PubMed ID: 15928819
[No Abstract] [Full Text] [Related]
35. Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist.
Esbenshade TA; Browman KE; Miller TR; Krueger KM; Komater-Roderwald V; Zhang M; Fox GB; Rueter L; Robb HM; Radek RJ; Drescher KU; Fey TA; Bitner RS; Marsh K; Polakowski JS; Zhao C; Cowart MD; Hancock AA; Sullivan JP; Brioni JD
J Pharmacol Exp Ther; 2012 Oct; 343(1):233-45. PubMed ID: 22815533
[TBL] [Abstract][Full Text] [Related]
36. Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576.
Chauhan NB; Siegel GJ; Feinstein DL
Neuropharmacology; 2005 Jan; 48(1):93-104. PubMed ID: 15617731
[TBL] [Abstract][Full Text] [Related]
37. GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression.
Pláteník J; Fišar Z; Buchal R; Jirák R; Kitzlerová E; Zvěřová M; Raboch J
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():83-93. PubMed ID: 24334212
[TBL] [Abstract][Full Text] [Related]
38. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
39. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
[TBL] [Abstract][Full Text] [Related]
40. Maintained activity of glycogen synthase kinase-3beta despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model.
Lim YW; Yoon SY; Choi JE; Kim SM; Lee HS; Choe H; Lee SC; Kim DH
Biochem Biophys Res Commun; 2010 Apr; 395(2):207-12. PubMed ID: 20362550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]